| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/26/2009 | CN101516912A Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same |
| 08/26/2009 | CN101516398A Antagonists of protease activated receptor-1 (PAR1) |
| 08/26/2009 | CN101516397A Treatment of multiple sclerosis (MS) with CAMPATH-1H |
| 08/26/2009 | CN101516396A Vaccine composition containing synthetic adjuvant |
| 08/26/2009 | CN101516395A A vaccine for chikungunya virus infection |
| 08/26/2009 | CN101516394A Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses |
| 08/26/2009 | CN101516393A Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins |
| 08/26/2009 | CN101516359A Medicament for lct poisoning |
| 08/26/2009 | CN101514334A Chicken infectivity bronchitis virus attenuated vaccine strain and application thereof |
| 08/26/2009 | CN101514333A Immunologic tolerance dendritic cell, preparation method thereof and special culture medium |
| 08/26/2009 | CN101514230A Monoclone antibody of ARD1 and application thereof |
| 08/26/2009 | CN101514179A Indolone hydrazine ethylidene carbonyl compound, method for preparing same and application thereof in medicine |
| 08/26/2009 | CN101513527A Bivalent inactivated vaccine against gosling plague and goose paramyxovirus disease and preparation method thereof |
| 08/26/2009 | CN101513526A Application of combined vaccine in treating tumors |
| 08/26/2009 | CN100532563C Pharmaceutical product comprising tissue of the male vegetal reproductive system |
| 08/26/2009 | CN100532549C Genes and polypeptides relating to human colon cancers |
| 08/26/2009 | CN100532548C Method of increasing yield of human papilloma virus L1 albumen pronucleus expression |
| 08/26/2009 | CN100531798C Combination therapies for B-cell lynphomas comprising administration of anti-CD20 antibody |
| 08/26/2009 | CN100531796C FGFR agonists |
| 08/26/2009 | CN100531794C Compositions and methods for modifying toxic effects of protein compounds |
| 08/25/2009 | US7579452 immunogenic composition comprising a polynucleotide encoding a nonfunctional mutant Brother of Regulator of Imprinted Sites (BORIS) protein; vaccine against cancer; biodrug delivery of specific nucleic acid |
| 08/25/2009 | US7579448 Adding to the microbial fermentation broth or homogenate, a solution of 6,9-diamino-2-ethoxyacridine lactate (ethacridine lactate) to precipitate host cell impurities, polypeptide remains soluble, separating the desiered polypeptide |
| 08/25/2009 | US7579447 Antibodies against LLG polypeptides of the triacylglycerol lipase family |
| 08/25/2009 | US7579446 Rabies virus G protein specific immunoglobulin for use in prevention and treatment of viral infections |
| 08/25/2009 | US7579445 Reagents and methods for inducing an immune response to prostate specific antigen |
| 08/25/2009 | US7579441 Interleukins; immunoglobulins; for stimulating proliferation and/or development of hematopoietic cells in vitro and in vivo |
| 08/25/2009 | US7579439 Modulation of IL-2- and IL-15-mediated T cell responses |
| 08/25/2009 | US7579438 Use of the gene NcSAG4 for the diagnosis and prevention of neosporosis and as a marker for analysis of the pathogenesis |
| 08/25/2009 | US7579330 Methods of treating various cancers using melanoma differentiation associated protein-7 |
| 08/25/2009 | US7579328 DNA vaccination for treatment of multiple sclerosis and insulin-dependent diabetes mellitus |
| 08/25/2009 | US7579320 Inhibitors of apoptosis proteins (IAP); antiproliferative agents; anticancer agents |
| 08/25/2009 | US7579316 Compositions and methods to modulate an immune response to an immunogenic therapeutic agent |
| 08/25/2009 | US7579187 Anti-A33 antibody |
| 08/25/2009 | US7579186 Human monoclonal antibody against TGF-β type II receptor and medicinal use thereof |
| 08/25/2009 | US7579182 against tularemia; subcellular protein expressed from Francisella tularensis infected mammal subculture growing in synthetic salts medium of weak acidity |
| 08/25/2009 | US7579173 Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using the same |
| 08/25/2009 | US7579170 Method for preparing monoclonal antibodies capable of activating effector cells expressing FCγRIII |
| 08/25/2009 | US7579169 producing a mutant HH polypeptide by transforming isolated host cells with a vector capable of expressing the polypeptide from the nucleic acid sequence; diagnosis, prenatal screening and diagnosis, and therapies of blood disorders |
| 08/25/2009 | US7579160 Cervical Cancer; Using monoclonal antibody comprising immunostimulant domains to diagnose and treat cell proliferative disorders; binding; lung tumor polypeptides, immunogenic portions, polynucleotides that encode such polypeptides, antigen presenting , T cells that are specific; |
| 08/25/2009 | US7579144 Using presence of enteroviral antigen in stomach as diagnostic tool in detection of sleeping disorders |
| 08/25/2009 | US7579141 Method of in vitro diagnosis which discriminates between exposure of a subject to Mycobacterium tuberculosis and vaccination with Bacille Calmette Guerin strain of Mycobacterium bovis, method comprising testing for presence of CD4 T lymphocytes that respond to MTBN4 |
| 08/25/2009 | US7579012 Targeting of triacylglycerol synthase gene for tuberculosis treatment |
| 08/25/2009 | US7579011 isolated polypeptide use in vaccines against A. salmonicida infections such as fish disease furunculosis |
| 08/25/2009 | US7579010 Botulinum toxin pharmaceutical compositions with a recombinant human serum albumin |
| 08/25/2009 | US7579009 a whole cell of a bacterium from the genera Rhodococcus, Gordonia, Nocardia, Dietzia, Tsukamurella and Nocardioides and at least one antigen or antigenic determinant; tuberculosis and leishmaniasis; vaccines |
| 08/25/2009 | US7579008 Immunization with an attenuated human rotavirus |
| 08/25/2009 | US7579007 Production of “biological carriers” for induction of immune responses and inhibition of viral replication |
| 08/25/2009 | US7579006 Method of treating immune pathologies with low dose estrogen |
| 08/25/2009 | US7579005 Process for recombinant expression and purification of antimicrobial peptides using periplasmic targeting signals as precipitable hydrophobic tags |
| 08/25/2009 | US7579004 diagnosing measles virus infection or immunity to measles virus in a human patient, by analyzing the sample from patients for the presence of the peptides or antibodies to the peptide |
| 08/25/2009 | US7579003 HBsAg-BCG combined vaccine for intracutaneous injection and preparation method thereof |
| 08/25/2009 | US7579002 Method for improving body weight uniformity and increasing carcass yield in animals |
| 08/25/2009 | US7579001 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 08/25/2009 | US7579000 Tissue factor targeted antibodies as anticoagulants |
| 08/25/2009 | US7578999 Antibodies specific for sclerostin |
| 08/25/2009 | CA2372456C Viral infection inhibitor targeting integrase n-terminal domain |
| 08/25/2009 | CA2349274C Assay for anti transglutaminase antibodies |
| 08/25/2009 | CA2088889C Specific antibodies against activated platelets, the preparation thereof and the use thereof in diagnosis and therapy |
| 08/20/2009 | WO2009103037A1 Methods and compositions for reducing the impact of enteric diseases |
| 08/20/2009 | WO2009103035A2 Templated open flocs of anisotropic particles for enhanced pulmonary delivery |
| 08/20/2009 | WO2009102909A2 Anti-cancer vaccines |
| 08/20/2009 | WO2009102509A2 Vaccines and diagnostics for ehrlichia chaffeensis |
| 08/20/2009 | WO2009102493A2 Use of egfrviii to identify and target cancer stem cells |
| 08/20/2009 | WO2009102473A2 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 08/20/2009 | WO2009102229A1 Lipid-protein raft complex made of the influenza a virus shell for anti-influenza vaccines and a method for the isolation thereof, a method for producing virus-like particles from such complexes |
| 08/20/2009 | WO2009101968A1 Anti-adam-15 antibodies and utilization of the same |
| 08/20/2009 | WO2009101614A1 Casein particles encapsulating therapeutically active agents and uses thereof |
| 08/20/2009 | WO2009101611A1 Monoclonal antibodies for tumor treatment |
| 08/20/2009 | WO2009101604A2 Recombinant lumpy skin disease virus for preventing aids |
| 08/20/2009 | WO2009101475A2 Use of glycosylceramides for enhancing the immune response to antigens |
| 08/20/2009 | WO2009101403A1 Hybrid polypeptides comprising gbs-80 and spb1 proteins of streptococcus |
| 08/20/2009 | WO2009101206A2 Strategies to prevent and/or treat immune responses to soluble allofactors |
| 08/20/2009 | WO2009101205A2 Immunogenic control of tumours and tumour cells |
| 08/20/2009 | WO2009101204A2 Elimination of immune responses to viral vectors |
| 08/20/2009 | WO2009100942A1 Ligands of the natural killer (nk) cell surface marker cd27 and therapeutic uses thereof |
| 08/20/2009 | WO2009080934A3 Allergen desensitization method |
| 08/20/2009 | WO2009079731A3 Vaccine comprising toxoplasma gondii surface proteins |
| 08/20/2009 | WO2009079242A3 Aglycosylated immunoglobulin mutants |
| 08/20/2009 | WO2009076966A3 Rhoc-based immunotherapy |
| 08/20/2009 | WO2009073104A3 Simian e adenoviruses sadv-39, -25. 2, -26, -30, -37, and -38 |
| 08/20/2009 | WO2009070294A3 Inhibition of macrophage-stimulating protein receptor (ron) and methods of treatment thereof |
| 08/20/2009 | WO2009069983A3 A pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate |
| 08/20/2009 | WO2009056631A3 Molecules and methods for modulating complement component |
| 08/20/2009 | WO2009053604A3 Influenza virus haemagglutinin-specific monoclonal antibodies |
| 08/20/2009 | WO2009038760A3 Human gm-csf antigen binding proteins |
| 08/20/2009 | WO2009030684A3 Reduction of concomitant infections in pigs by the use of pcv2 antigen |
| 08/20/2009 | WO2009023360A3 Bacterial packaging strains useful for generation and production of recombinant double-stranded rna nucleocapsids and uses thereof |
| 08/20/2009 | WO2009012156A3 Treatments and diagnostics for cancer, inflammatory disorders and autoimmune disorders |
| 08/20/2009 | WO2007021841A9 Identification and engineering of antibodies with variant fc regions and methods of using same |
| 08/20/2009 | US20090210954 Genes |
| 08/20/2009 | US20090209937 Apparatus and Methods for Treating Epilepsy Using Convection-Enhanced Delivery |
| 08/20/2009 | US20090209905 Compositions comprising chitin microparticles and their medical uses |
| 08/20/2009 | US20090209734 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 08/20/2009 | US20090209729 Recombinant chemokine-antigen vaccine |
| 08/20/2009 | US20090209470 T24 antigen for immunodiagnosis of taenia solium cysticercosis |
| 08/20/2009 | US20090209464 inhibiting Flavivirus infection by inhibiting the fusion between the virion envelope and a cell membrane; E1 envelope glycoprotein of hepaciviruses and E2 envelope glycoprotein of pestivirus have previously undescribed structures, truncated class II fusion proteins |
| 08/20/2009 | US20090209034 Tumour rejection antigens |
| 08/20/2009 | US20090209006 Taci-immunoglobulin fusion proteins |
| 08/20/2009 | US20090208972 Cytotoxic protein and utlization thereof |
| 08/20/2009 | US20090208938 Use of the MCM8 Gene for the Preparation of a Pharmaceutical Composition |